[go: up one dir, main page]

WO2007012841A3 - Compositions comprising monobutyrin - Google Patents

Compositions comprising monobutyrin Download PDF

Info

Publication number
WO2007012841A3
WO2007012841A3 PCT/GB2006/002778 GB2006002778W WO2007012841A3 WO 2007012841 A3 WO2007012841 A3 WO 2007012841A3 GB 2006002778 W GB2006002778 W GB 2006002778W WO 2007012841 A3 WO2007012841 A3 WO 2007012841A3
Authority
WO
WIPO (PCT)
Prior art keywords
monobutyrin
compositions
regeneration
promoting
musculo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2006/002778
Other languages
French (fr)
Other versions
WO2007012841A2 (en
Inventor
Andrew Harrison
Ed Margerrison
Robert Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
Original Assignee
Smith and Nephew PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith and Nephew PLC filed Critical Smith and Nephew PLC
Publication of WO2007012841A2 publication Critical patent/WO2007012841A2/en
Publication of WO2007012841A3 publication Critical patent/WO2007012841A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to compositions/medicaments, devices and methods for treating musculo-skeletal tissue. The pharmaceutical composition for promoting musculo-skeletal tissue repair, regeneration and/or formation comprises monobutyrin and/or derivatives, fragments and/or analogues thereof, and a second agent capable of promoting musculoskeletal tissue repair, regeneration and/or formation.
PCT/GB2006/002778 2005-07-28 2006-07-25 Compositions comprising monobutyrin Ceased WO2007012841A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0515477.8 2005-07-28
GBGB0515477.8A GB0515477D0 (en) 2005-07-28 2005-07-28 Composition

Publications (2)

Publication Number Publication Date
WO2007012841A2 WO2007012841A2 (en) 2007-02-01
WO2007012841A3 true WO2007012841A3 (en) 2007-08-16

Family

ID=34976736

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/002778 Ceased WO2007012841A2 (en) 2005-07-28 2006-07-25 Compositions comprising monobutyrin

Country Status (2)

Country Link
GB (1) GB0515477D0 (en)
WO (1) WO2007012841A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137734A (en) * 1989-03-22 1992-08-11 Dana Farber Cancer Institute Angiogenic monoglycerides
WO2002100426A1 (en) * 2001-06-08 2002-12-19 Smith & Nephew Plc Bmp binding proteins for use in bone or cartilage regeneration
US20030055511A1 (en) * 2000-03-03 2003-03-20 Schryver Jeffrey E. Shaped particle comprised of bone material and method of making the particle
WO2005025634A2 (en) * 2003-05-21 2005-03-24 Dexcom, Inc. Biointerface membranes incorporating bioactive agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137734A (en) * 1989-03-22 1992-08-11 Dana Farber Cancer Institute Angiogenic monoglycerides
US20030055511A1 (en) * 2000-03-03 2003-03-20 Schryver Jeffrey E. Shaped particle comprised of bone material and method of making the particle
WO2002100426A1 (en) * 2001-06-08 2002-12-19 Smith & Nephew Plc Bmp binding proteins for use in bone or cartilage regeneration
WO2005025634A2 (en) * 2003-05-21 2005-03-24 Dexcom, Inc. Biointerface membranes incorporating bioactive agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BUDAVARI S ED - MARYADELE J O'NEIL ET AL: "The Merck index, Thirteenth Edition, Monograph No 1322", MERCK INDEX. AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS, WHITEHOUSE STATION, NJ : MERCK & CO, US, 2001, pages 223, XP002424775, ISBN: 0-911910-13-1 *

Also Published As

Publication number Publication date
GB0515477D0 (en) 2005-08-31
WO2007012841A2 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
WO2006121861A3 (en) Biphenylazetidinone cholesterol absorption inhibitors
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2008024439A3 (en) 4-aminoquinazoline derivatives and methods of use thereof
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2007084424A3 (en) Treatment of substance abuse
WO2007064931A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2006102674A3 (en) Diphenylheterocycle cholesterol absorption inhibitors
WO2007121088A3 (en) Combinations of therapeutic agents for treating cancer
WO2007123740A3 (en) Pharmaceutical compositions for promoting wound healing
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
MX2007014920A (en) Combination therapy comprising diaryl ureas for treating diseases.
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2007146335A3 (en) Compounds and compositions for treatment of cancer
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2004009091A8 (en) Purine derivatives as liver x receptor agonists
WO2007056142A3 (en) Methods of preventing the serotonin syndrome and compositions for use therefor
WO2008099190A3 (en) Osteogenic compounds
WO2009016214A3 (en) N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06765102

Country of ref document: EP

Kind code of ref document: A2